Vivitra 440 mg Injection

Vivitra 440 mg Injection contains trastuzumab, a monoclonal antibody used to treat certain types of breast and gastric cancers. It works by targeting and binding to the HER2 (human epidermal growth factor receptor 2) protein present on the surface of cancer cells, blocking their growth and reducing tumor proliferation.

Uses:

1. HER2-Positive Breast Cancer: Used as part of a treatment regimen for early-stage and metastatic HER2-positive breast cancer.
2. HER2-Positive Gastric Cancer: Indicated for advanced or metastatic HER2-positive gastric cancer, often used in combination with other cancer therapies.

How Vivitra Works: Trastuzumab specifically binds to the HER2 receptors on cancer cells, interfering with their growth and survival. This targeted approach helps slow down or stop the spread of HER2-positive tumors, often used in combination with chemotherapy or as monotherapy depending on the cancer stage.

Common Side Effects:

• Fever, chills, or flu-like symptoms
• Fatigue
• Nausea, vomiting, or diarrhea
• Mild rash or allergic reactions

Serious Side Effects (Seek Immediate Medical Attention):

• Heart problems, including heart failure
• Severe infusion-related reactions, such as difficulty breathing, low blood pressure, or chest pain
• Lung problems, including inflammation
• Serious infections or liver dysfunction

Key Features:

• Contains trastuzumab, a targeted therapy for HER2-positive cancer.
• Reduces cancer cell growth by binding specifically to HER2 receptors.
• Proven efficacy for breast and gastric cancer treatment, often used with other therapies.
• Administered as an intravenous infusion under professional supervision.

Frequently Asked Questions (FAQ):

1. How is Vivitra 440 mg Injection administered?
   It is given as an intravenous infusion in a healthcare facility, usually under the supervision of an oncologist.
2. Is Vivitra effective as a standalone treatment?
   Depending on the stage and condition of the cancer, it may be used alone or in combination with other treatments such as chemotherapy.
3. Can Vivitra cause heart problems?
   Yes, trastuzumab can cause heart-related issues in some patients. Regular cardiac monitoring is recommended during treatment.
4. Is Vivitra safe during pregnancy?
   No, it can harm the fetus. Effective contraception must be used during treatment and for a period after the final dose.

References:

1. Roche Pharmaceuticals – Trastuzumab Information
   Available from: https://www.ncbi.nlm.nih.gov/books/NBK532246
2. Cancer Treatment Guidelines – HER2-Positive Therapies
   Available from: https://www.cancerresearchuk.org/about-cancer/treatment/drugs/trastuzumab